What type of study is this?

Predicting Postoperative Pneumonia in ESCC After Neoadjuvant Chemo-Immunotherapy: Combined Use of ARISCAT Score and Inflammatory Biomarkers

View Full Paper

Ask AI

Bookmark

Authors

Retrospective analysis identifies pneumonia predictors in esophageal cancer patients, suggesting improvements in risk assessment.

Postoperative pneumonia occurred in 27.6% of ESCC patients after surgery, highlighting a significant complication risk.
Patients with pneumonia had significantly higher ARISCAT scores (53.9) compared to those without (37.4), indicating its predictive value.
Logistic regression analysis confirmed ARISCAT, NLR, and SII as independent predictors of pneumonia in this cohort.
Integration of ARISCAT with inflammatory biomarkers showed improved model discrimination and calibration, enhancing preoperative risk assessment.

Ding et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark